Drug Discovery and Evaluation: Methods in Clinical Pharmacology

Drug Discovery and Evaluation has become a more and more difficult, expensive and time-consuming process. The effect of a new compound has to be detected by in vitro and in vivo methods of pharmacology. The activity spectrum and the potency compared to existing drugs have to be determined. As these...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Vogel, Hans Gerhard (Επιμελητής έκδοσης), Maas, Jochen (Επιμελητής έκδοσης), Gebauer, Alexander (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2011.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02681nam a22004215i 4500
001 978-3-540-89891-7
003 DE-He213
005 20151204191458.0
007 cr nn 008mamaa
008 101224s2011 gw | s |||| 0|eng d
020 |a 9783540898917  |9 978-3-540-89891-7 
024 7 |a 10.1007/978-3-540-89891-7  |2 doi 
040 |d GrThAP 
050 4 |a RM1-950 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
082 0 4 |a 615  |2 23 
245 1 0 |a Drug Discovery and Evaluation: Methods in Clinical Pharmacology  |h [electronic resource] /  |c edited by Hans Gerhard Vogel, Jochen Maas, Alexander Gebauer. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2011. 
300 |a 138 illus. eReference.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a Drug Discovery and Evaluation has become a more and more difficult, expensive and time-consuming process. The effect of a new compound has to be detected by in vitro and in vivo methods of pharmacology. The activity spectrum and the potency compared to existing drugs have to be determined. As these processes can be divided up stepwise we have designed a book series "Drug Discovery and Evaluation" in the form of a recommendation document. The methods to detect drug targets are described in the first volume of this series "Pharmacological Assays" comprising classical methods as well as new technologies. Before going to man, the most suitable compound has to be selected by pharmacokinetic studies and experiments in toxicology. These preclinical methods are described in the second volume „Safety and Pharmacokinetic Assays". Only then are first studies in human beings allowed. Special rules are established for Phase I studies. Clinical pharmacokinetics are performed in parallel with human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: „Methods in Clinical Pharmacology". 
650 0 |a Medicine. 
650 0 |a Pharmacology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmacology/Toxicology. 
700 1 |a Vogel, Hans Gerhard.  |e editor. 
700 1 |a Maas, Jochen.  |e editor. 
700 1 |a Gebauer, Alexander.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540898900 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-89891-7  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)